• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在固相载体上合成环肽。在流感病毒血凝素类似物中的应用。

Synthesis of cyclic peptides on solid support. Application to analogs of hemagglutinin of influenza virus.

作者信息

Plaué S

机构信息

Neosystem S.A., Strasbourg, France.

出版信息

Int J Pept Protein Res. 1990 Jun;35(6):510-7. doi: 10.1111/j.1399-3011.1990.tb00255.x.

DOI:10.1111/j.1399-3011.1990.tb00255.x
PMID:2401592
Abstract

In order to mimic a well-known loop structure (site A) of the hemagglutinin of influenza virus, a series of cyclic peptides derived from the region 139-147 were synthesized. The lactam analogs cyclised between the N-terminus Cys 139 and the beta-carboxyl of aspartic acid 148 (small loop) or the epsilon-NH2 of lysine 148 via succinimidyl linker (large loop) were synthesized by the solid phase method. Cyclisation was directly performed on the solid support prior to final cleavage of the peptide. We describe two protection schemes which allow us to obtain different loop sizes derived from the same sequence. Eight of the analogs contained relatively large ring structures (up to 38 membered). For protection of the side chain of aspartic acid in combination with N-alpha-Fmoc protection, the cyclohexyl ester was more satisfactory than the benzyl ester with respect to imide formation. When the rate of cyclodimerisation, as a function of resin substitution, was compared to the rate of cyclic monomer formation, it was found that dimerisation was proportional to the charge of the resin. Furthermore, a comparison of the recently reported BOP reagent over the classical DIPC/HOBt method for the cyclisation reaction shows that in our case the reaction proceeded more rapidly by the BOP procedure although it gave a less pure crude product.

摘要

为了模拟流感病毒血凝素的一种著名环结构(位点A),合成了一系列源自139 - 147区域的环肽。通过固相法合成了内酰胺类似物,其在N端半胱氨酸139与天冬氨酸148的β - 羧基(小环)之间或通过琥珀酰亚胺连接子在赖氨酸148的ε - NH2之间环化(大环)。环化在肽最终裂解之前直接在固相载体上进行。我们描述了两种保护方案,它们使我们能够从相同序列获得不同的环大小。其中八个类似物含有相对较大的环结构(多达38元环)。对于天冬氨酸侧链的保护并结合N - α - Fmoc保护,就酰亚胺形成而言,环己酯比苄酯更令人满意。当将作为树脂取代度函数的环二聚化速率与环单体形成速率进行比较时,发现二聚化与树脂的电荷成正比。此外,将最近报道的BOP试剂用于环化反应与经典的DIPC/HOBt方法进行比较表明,在我们的情况下,BOP方法反应进行得更快,尽管它得到的粗产物纯度较低。

相似文献

1
Synthesis of cyclic peptides on solid support. Application to analogs of hemagglutinin of influenza virus.在固相载体上合成环肽。在流感病毒血凝素类似物中的应用。
Int J Pept Protein Res. 1990 Jun;35(6):510-7. doi: 10.1111/j.1399-3011.1990.tb00255.x.
2
Self-assembly of cyclic peptides on a dendrimer: multiple cyclic antigen peptides.树枝状大分子上环状肽的自组装:多种环状抗原肽
Pept Res. 1996 Nov-Dec;9(6):290-6.
3
Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin.对应于流感病毒血凝素A位点的环肽的抗原特性及保护能力
Vaccine. 1990 Aug;8(4):308-14. doi: 10.1016/0264-410x(90)90086-2.
4
A new tri-orthogonal strategy for peptide cyclization.一种用于肽环化的新型三正交策略。
Org Lett. 2002 Sep 19;4(19):3219-21. doi: 10.1021/ol026416u.
5
Solid-phase synthesis of cyclic analogues related to the hypoglycaemic peptide hGH(6-13): comparison of two i-->i + 4 lactam cyclization procedures.与降血糖肽hGH(6 - 13)相关的环状类似物的固相合成:两种i→i + 4内酰胺环化方法的比较
J Pept Sci. 2001 Oct;7(10):529-36. doi: 10.1002/psc.343.
6
Studies on conformational consequences of i to i + 3 side-chain cyclization in model cyclic tetrapeptides.模型环四肽中i至i + 3侧链环化的构象后果研究。
Int J Pept Protein Res. 1995 May;45(5):418-29. doi: 10.1111/j.1399-3011.1995.tb01057.x.
7
Solid-phase synthesis of extended lactam ring systems: preparation of amino acid alpha-fluorenylmethyl esters for the synthesis of reverse-extended lactams.扩展内酰胺环系统的固相合成:用于合成反向扩展内酰胺的氨基酸α-芴甲基酯的制备。
Pept Res. 1994 Jul-Aug;7(4):218-23.
8
A tandem in situ peptide cyclization through trifluoroacetic acid cleavage.通过三氟乙酸裂解实现串联原位肽环化。
Angew Chem Int Ed Engl. 2014 Sep 1;53(36):9450-5. doi: 10.1002/anie.201402789. Epub 2014 May 14.
9
Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.P物质C末端六肽的NK-1选择性、N-主链环类似物的合成与生物活性
J Med Chem. 1996 Aug 2;39(16):3174-8. doi: 10.1021/jm960154i.
10
Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.基于内吗啡肽-2结构的环五肽类似物:使用液相色谱结合在线质谱和串联质谱的环化研究。
Peptides. 2014 May;55:32-40. doi: 10.1016/j.peptides.2014.02.001. Epub 2014 Feb 10.

引用本文的文献

1
Peptide-Carrier Conjugation.肽-载体偶联。
Methods Mol Biol. 2024;2821:57-63. doi: 10.1007/978-1-0716-3914-6_4.
2
Global analysis of peptide cyclization efficiency.肽环化效率的全局分析。
ACS Comb Sci. 2013 Feb 11;15(2):120-9. doi: 10.1021/co300136j. Epub 2013 Jan 7.
3
Exploring privileged structures: the combinatorial synthesis of cyclic peptides.探索优势结构:环肽的组合合成
Mol Divers. 2002;5(4):289-304. doi: 10.1023/a:1021365402751.
4
Exploring privileged structures: the combinatorial synthesis of cyclic peptides.探索优势结构:环肽的组合合成
J Comput Aided Mol Des. 2002 May-Jun;16(5-6):415-30. doi: 10.1023/a:1020863921840.
5
Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.含有设计为延伸出HLA - A2结合位点的大聚乙二醇环的抗原肽与I类主要组织相容性复合体分子形成稳定复合物。
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4583-8. doi: 10.1073/pnas.93.10.4583.
6
Synthesis of cyclic penta- and hexapeptides: a general synthetic strategy on DAS resin.
J Protein Chem. 1994 Apr;13(3):339-46. doi: 10.1007/BF01901567.
7
Structural and dynamic studies of two antigenic loops from haemagglutinin: a relaxation matrix approach.血凝素两个抗原环的结构与动力学研究:一种弛豫矩阵方法
J Biomol NMR. 1993 Jan;3(1):91-112. doi: 10.1007/BF00242478.
8
Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides.利用线性和环化合成肽对菜豆荚斑驳病毒进行抗原分析。
Arch Virol. 1993;128(3-4):299-317. doi: 10.1007/BF01309441.
9
Protein antigenicity.蛋白质抗原性
Mol Biol Rep. 1992 Jun;16(3):133-8. doi: 10.1007/BF00464700.